Patent intelligence · US
US 9801942
Etanercept formulations stabilized with metal ions
Etanercept formulations stabilized with metal ions
Patent details — US 9801942
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 31, 2017
- Expiration
- Oct 26, 2037
- Applicant
- Coherus BioSciences, Inc.
- Claims
- 24
- CPC classes
- A61K, A61K38/17, A61K38/1793, A61K38/191
Quick answer
US 9801942 (Etanercept formulations stabilized with metal ions) is held by Coherus BioSciences, Inc.. Status: granted. Granted Oct 31, 2017. Expires Oct 26, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Coherus BioSciences, Inc.
- Grant date
- Expiration
- Claims
- 24
- CPC classes
- A61K, A61K38/17, A61K38/1793, A61K38/191, A61K39/39591, A61K47/10
More from Coherus BioSciences, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 11667702
Stable aqueous formulations of aflibercept
granted -
US 11583584
Stable protein compositions and methods of their use
granted -
US 11576971
Method of filling a container with no headspace
granted -
US 11426446
Stable aqueous formulations of aflibercept
granted -
US 11400072
Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
granted -
US 11396540
Methods for making recombinant proteins
granted -
US 11253508
PPARy agonist for treatment of progressive supranuclear palsy
granted -
US 11229702
High concentration formulations of adalimumab
granted
Related coverage
Frequently asked questions
What is US patent 9801942?
US 9801942 (Etanercept formulations stabilized with metal ions) is held by Coherus BioSciences, Inc.. Status: granted. Granted Oct 31, 2017. Expires Oct 26, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9801942?
Coherus BioSciences, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 73 pharmaceutical patents for this assignee.
When does US 9801942 expire?
Our index shows an expiration date of Oct 26, 2037 (11 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.